| Dr Lynn Ann Bailey, MD | |
|
Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 | |
| (011) 814-68968728 | |
| Not Available |
| Full Name | Dr Lynn Ann Bailey |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Usnh Yokosuka Japan, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144206566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | G72744 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynn Ann Bailey, MD Psc 475 Box 1739, Fpo, AP 96350 Ph: () - | Dr Lynn Ann Bailey, MD Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 Ph: (011) 814-68968728 |
News Archive
Health Information & the Law, a project at the George Washington University School of Public Health and Health Services (SPHHS), released new resources on a website that offers easy-to-understand content on key issues related to the use and exchange of health information and how it affects the transformation of the U.S. health care system to a patient-centered, value-based system.
Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.
Chindex International, Inc., a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the third quarter and first nine months of fiscal year 2010.
Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
› Verified 2 days ago
Katherine Maureen Carlin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Us Naval Hospital Okinawa, Camp Foster, Fpo, AP 96362 Phone: 315-646-7488 | |
Dr. Thomas Arthur Pluim Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Psc 490, Box 7668, Fpo, AP 96530 Phone: 671-486-5084 | |
Meghan Leigh Jarman, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Usnh Okinawa, Fpo, AP 96362 Phone: 315-646-7488 | |
Dr. Frances Lauren Rosario, M.D., MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5505 | |
Dr. Heather Soloria, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: U.s. Naval Hospital Guam, Psc 455, Fpo, AP 96540 Phone: 671-344-9543 |